Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Biotechnology

HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF64
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF63
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF61
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF49
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF48
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA-TRUMP
RTX7ZF47
October 02, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrisville, North Carolina, U.S., July 27, 2020. Picture taken July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFSQ
August 13, 2020
A laboratory technician of biotechnology company mAbxience is seen working, amid the outbreak of the...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
A laboratory technician of biotechnology company mAbxience is seen working, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFSS
August 13, 2020
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFST
August 13, 2020
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
The logo of biotechnology company mAbxience is seen on the facade of its building, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
HEALTH-CORONAVIRUS/ARGENTINA-VACCINE
RTX7PFSR
August 13, 2020
Laboratory technicians of biotechnology company mAbxience are seen as they work, amid the outbreak of...
Outbreak of the coronavirus disease (COVID-19) in Buenos Aires
Laboratory technicians of biotechnology company mAbxience are seen as they work, amid the outbreak of the coronavirus disease (COVID-19), in Buenos Aires, Argentina August 13, 2020. REUTERS/Agustin Marcarian
MOLECULAR PARTNERS-SWISS/
RTX7OXO9
August 11, 2020
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a...
SCHLIEREN, Switzerland
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a...
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a petri dish containing bacterial colonies in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXNW
August 11, 2020
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
SCHLIEREN, Switzerland
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXNY
August 11, 2020
An employee of Swiss biotechnology company Molecular Partners takes samples out of a colony picker robot...
SCHLIEREN, Switzerland
An employee of Swiss biotechnology company Molecular Partners takes samples out of a colony picker robot...
An employee of Swiss biotechnology company Molecular Partners takes samples out of a colony picker robot in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXNX
August 11, 2020
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
SCHLIEREN, Switzerland
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory...
An employee of Swiss biotechnology company Molecular Partners controls a colony picker robot in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMP
August 11, 2020
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
SCHLIEREN, Switzerland
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMN
August 11, 2020
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
SCHLIEREN, Switzerland
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a...
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMF
August 11, 2020
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's...
SCHLIEREN, Switzerland
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in Schlieren
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's logo in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXMD
August 11, 2020
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's...
SCHLIEREN, Switzerland
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in Schlieren
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's logo in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXM1
August 11, 2020
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's...
SCHLIEREN, Switzerland
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in Schlieren
CEO Patrick Amstutz of Swiss biotechnology company Molecular Partners poses in front of the company's logo in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
MOLECULAR PARTNERS-SWISS/
RTX7OXLS
August 11, 2020
The logo of Swiss biotechnology company Molecular Partners is seen at the company's headquarters in Schlieren,...
SCHLIEREN, Switzerland
Logo of Swiss biotechnology company Molecular Partners is seen in Schlieren
The logo of Swiss biotechnology company Molecular Partners is seen at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann
HEALTH-CORONAVIRUS/USA
RTX7M5CL
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M5CK
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M5A2
July 27, 2020
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for the potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M58S
July 27, 2020
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for the potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M58J
July 27, 2020
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump faces a staff member during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for the potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M57Q
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria TPX IMAGES OF THE DAY
HEALTH-CORONAVIRUS/USA
RTX7M579
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M56X
July 27, 2020
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M569
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M561
July 27, 2020
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate Novavax are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M549
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M53Y
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M53Z
July 27, 2020
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump gestures during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M518
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M517
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M50Z
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M50R
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M50T
July 27, 2020
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump wears a protective face mask during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M507
July 27, 2020
U.S. President Donald Trump departs after delivering a speech during a tour of the Fujifilm Diosynth...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump departs after delivering a speech during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M508
July 27, 2020
U.S. President Donald Trump departs after delivering a speech as a member of his U.S. Secret Service...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump departs after delivering a speech as a member of his U.S. Secret Service detail keeps watch during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4ZO
July 27, 2020
U.S. President Donald Trump arrives to deliver remarks as a member of his U.S. Secret Service detail...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump arrives to deliver remarks as a member of his U.S. Secret Service detail keeps watch at the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4XM
July 27, 2020
U.S. President Donald Trump delivers a speech during a visit to the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump delivers a speech during a visit to the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4WB
July 27, 2020
White House senior advisor Jared Kushner looks on as U.S. President Donald Trump delivers a speech at...
Morrisville, UNITED STATES
White House senior advisor Jared Kushner attends Trump visit to Fujifilm Diosynth Biotechnologies' Innovation...
White House senior advisor Jared Kushner looks on as U.S. President Donald Trump delivers a speech at the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4VR
July 27, 2020
U.S. President Donald Trump delivers a speech during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump delivers a speech during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4V6
July 27, 2020
U.S. President Donald Trump delivers a speech during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump delivers a speech during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4V5
July 27, 2020
U.S. President Donald Trump arrives to deliver remarks during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump arrives to deliver remarks during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4UQ
July 27, 2020
U.S. President Donald Trump delivers a speech during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump delivers a speech during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4T8
July 27, 2020
U.S. President Donald Trump arrives to deliver remarks during a tour of the Fujifilm Diosynth Biotechnologies'...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
U.S. President Donald Trump arrives to deliver remarks during a tour of the Fujifilm Diosynth Biotechnologies' Innovation Center, a pharmaceutical manufacturing plant where components for a potential coronavirus disease (COVID-19) vaccine candidate are being developed, in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/USA
RTX7M4SV
July 27, 2020
Supporters watch as the motorcade of U.S. President Donald Trump passes by on its way to a tour of Fujifilm...
Morrisville, UNITED STATES
U.S. President Trump visits Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North...
Supporters watch as the motorcade of U.S. President Donald Trump passes by on its way to a tour of Fujifilm Diosynth Biotechnologies' Innovation Center in Morrrisville, North Carolina, U.S., July 27, 2020. REUTERS/Carlos Barria
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2DG
June 22, 2020
Professor Gottfried Kremsner injects a vaccination against the coronavirus disease (COVID-19) from German...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
Professor Gottfried Kremsner injects a vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac to a volunteer at the start of a clinical test series at his tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2D7
June 22, 2020
Professor Gottfried Kremsner injects a vaccination against the coronavirus disease (COVID-19) from German...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
Professor Gottfried Kremsner injects a vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac to a volunteer at the start of a clinical test series at his tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2D5
June 22, 2020
A vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac is...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
A vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac is ready to use at the start of a clinical test series in the tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2CZ
June 22, 2020
Professor Gottfried Kremsner answers journalists' questions prior to the start of the clinical test series...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
Professor Gottfried Kremsner answers journalists' questions prior to the start of the clinical test series with vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac at his tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2CQ
June 22, 2020
Professor Gottfried Kremsner arrives for the start of the clinical test series with vaccination against...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
Professor Gottfried Kremsner arrives for the start of the clinical test series with vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac at his tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2CN
June 22, 2020
Professor Gottfried Kremsner answers journalists' questions prior to the start of the clinical test series...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
Professor Gottfried Kremsner answers journalists' questions prior to the start of the clinical test series with vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac at his tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2CI
June 22, 2020
Professor Gottfried Kremsner answers journalists' questions prior to the start of the clinical test series...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
Professor Gottfried Kremsner answers journalists' questions prior to the start of the clinical test series with vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac at his tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/GERMNANY-CUREVAC
RTS3F2CH
June 22, 2020
Professor Gottfried Kremsner answers journalists questions prior to the start of the clinical test series...
Tuebingen, Germany
Outbreak of the coronavirus disease (COVID-19) in Tuebingen
Professor Gottfried Kremsner answers journalists questions prior to the start of the clinical test series with a vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac at his tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTS3CIYI
June 11, 2020
A scientist dilutes samples during the research and development of a vaccine against the coronavirus...
Saint Petersburg, Russia
Scientists develop a vaccine against the coronavirus disease in Saint Petersburg
A scientist dilutes samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia June 11, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTS3CIYD
June 11, 2020
A scientist dilutes samples during the research and development of a vaccine against the coronavirus...
Saint Petersburg, Russia
Scientists develop a vaccine against the coronavirus disease in Saint Petersburg
A scientist dilutes samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia June 11, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTS3CIXU
June 11, 2020
A scientist prepares samples during the research and development of a vaccine against the coronavirus...
Saint Petersburg, Russia
Scientists develop a vaccine against the coronavirus disease in Saint Petersburg
A scientist prepares samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia June 11, 2020. REUTERS/Anton Vaganov
Sort by
Display
Items per page
Page
of 18